XOMA's CEO Discusses Safety and Efficacy Study of Gevokizumab in Patients ... Seeking Alpha The most resounding message we've heard from our conversations with physicians during our planning phase has been given a drug that lets us get our patients off high-dose corticosteroids. They know the long-term health consequences these patients face ... XOMA Initiates Safety and Efficacy Study of Gevokizumab - Quick Facts |
